MRK

Dow 30 Trading Range Screen	Under the Hood: WisdomTree LargeCap Dividend Fund	Bristol-Myers to Cut 3 Percent of Its Workforce
Bristol-Myers to Cut 3 Percent of Its Workforce	Value Screening in an Improving Stock Market	Value Screening in an Improving Stock Market
Drug Approval Trends Remain Positive for 2010	Avandia Goes Down: A Researcher's Rant	Novartis Beats Merck in Race for Approval of First Oral MS Pill
26 Conservative Dividend Stocks That Should Beat Bonds	Merck / J&J Battle for Anti-Inflammatory Drug Rights Worth Billions	24 Companies With Attractive Valuations That Pay Over 3% Dividend Yield
Fall Earnings Season Starts: What to Watch For	Bigger Doors Open for Aveo as Merck Deal Closes	20 Highly Profitable Breakout Stocks
The Most Attractive European Stocks	Merck/Ariad Pharmaceuticals: Results of Synergistic Collaboration Coming Soon	CPI Tame in September
Depomed: Long-Term Winner Holding Strong	Analyzing Major Big Pharma Players Using Relative Valuation	Merck May Have Learned Its Lesson From Vytorin Scandal
Do Bank Stocks Belong in the Conservative Income Investor's Portfolio? - An Addendum	Five Stocks Keeping Company With Viagra	Five Stocks Keeping Company With Viagra

Main menu